Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Liebchen

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Scientific Reports|September 18, 2024
Correlation of bilirubin and toxic bile acids in critically ill patients with cholestatic liver dysfunction and adsorber applicationCaroline Gräfe, Helen Graf, Vassilissa Wustrow, et al.
Pharmaceutics|July 27, 2022
Simultaneous LC-ESI-MS/MS Quantification of Levosimendan and Its Metabolites for Therapeutic Drug Monitoring of Cardiac Surgery PatientsHannah Kipka, Roland Tomasi, Max Hübner, et al.
British Journal of Clinical Pharmacology|March 27, 2015
Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patientsMichael Schleibinger, Cathérine L Steinbach, Christoph Töpper, et al.
Journal of Critical Care|July 3, 2022
Serum linezolid concentrations are reduced in critically ill patients with pulmonary infections: A prospective observational studyMichael Zoller, Michael Paal, Antonia Greimel, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2021
Combination of Pharmacokinetic and Pathogen Susceptibility Information To Optimize Meropenem Treatment of Gram-Negative Infections in Critically Ill PatientsUwe Liebchen, Ferdinand Weinelt, Christina Scharf, et al.
Biomedicines|November 27, 2024
Angiopoietin II in Critically Ill Septic Patients: A Post Hoc Analysis of the DRAK StudyVeronika Bucher, Helen Graf, Johannes Zander, et al.
Pharmaceutics|September 23, 2022
Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill PatientsSimon Kallee, Christina Scharf, Lea Marie Schatz, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
The Role of Non-Enzymatic Degradation of Meropenem-Insights from the Bottle to the BodyUwe Liebchen, Sophie Rakete, Michael Vogeser, et al.
Journal of Pharmaceutical Sciences|September 21, 2017
Impact of Experimental Variables on the Protein Binding of Tigecycline in Human Plasma as Determined by UltrafiltrationChristoph Dorn, Alexander Kratzer, Uwe Liebchen, et al.
Renal Failure|September 20, 2023
The effect of cytosorb® application on kidney recovery in critically ill patients with severe rhabdomyolysis: a propensity score matching analysisCaroline Gräfe, Uwe Liebchen, Antonia Greimel, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Scientific Reports|September 18, 2024
Correlation of bilirubin and toxic bile acids in critically ill patients with cholestatic liver dysfunction and adsorber applicationCaroline Gräfe, Helen Graf, Vassilissa Wustrow, et al.
Pharmaceutics|July 27, 2022
Simultaneous LC-ESI-MS/MS Quantification of Levosimendan and Its Metabolites for Therapeutic Drug Monitoring of Cardiac Surgery PatientsHannah Kipka, Roland Tomasi, Max Hübner, et al.
British Journal of Clinical Pharmacology|March 27, 2015
Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patientsMichael Schleibinger, Cathérine L Steinbach, Christoph Töpper, et al.
Journal of Critical Care|July 3, 2022
Serum linezolid concentrations are reduced in critically ill patients with pulmonary infections: A prospective observational studyMichael Zoller, Michael Paal, Antonia Greimel, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2021
Combination of Pharmacokinetic and Pathogen Susceptibility Information To Optimize Meropenem Treatment of Gram-Negative Infections in Critically Ill PatientsUwe Liebchen, Ferdinand Weinelt, Christina Scharf, et al.
Biomedicines|November 27, 2024
Angiopoietin II in Critically Ill Septic Patients: A Post Hoc Analysis of the DRAK StudyVeronika Bucher, Helen Graf, Johannes Zander, et al.
Pharmaceutics|September 23, 2022
Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill PatientsSimon Kallee, Christina Scharf, Lea Marie Schatz, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
The Role of Non-Enzymatic Degradation of Meropenem-Insights from the Bottle to the BodyUwe Liebchen, Sophie Rakete, Michael Vogeser, et al.
Journal of Pharmaceutical Sciences|September 21, 2017
Impact of Experimental Variables on the Protein Binding of Tigecycline in Human Plasma as Determined by UltrafiltrationChristoph Dorn, Alexander Kratzer, Uwe Liebchen, et al.
Renal Failure|September 20, 2023
The effect of cytosorb® application on kidney recovery in critically ill patients with severe rhabdomyolysis: a propensity score matching analysisCaroline Gräfe, Uwe Liebchen, Antonia Greimel, et al.
Pageof 7